Key Highlights

  • 3 E Network Technology Group (NASDAQ:MASK) was down 10.45 percent at USD 2.15, with a hearing request planned by November 3, 2026.
  • RedCloud Holdings (NASDAQ:RCT) was down 33.10 percent at USD 0.0386, after appealing a delisting determination.
  • Caring Brands (NASDAQ:CABR) was up 9.73 percent at USD 1.24, with no announcement identified.
  • Gamehaus (NASDAQ:GMHS) was up 12.67 percent at USD 0.7335, with a minimum bid notice dated July 13, 2026.
  • Milestone Pharmaceuticals (NASDAQ:MIST) was up 9.32 percent at USD 0.7980, with a compliance deadline of April 21, 2027.

3 E Network Technology Group (NASDAQ:MASK): Hearing Request Due November 3

3 E Network Technology Group (NASDAQ:MASK) was down 10.45 percent to USD 2.15 in pre-market trading on November 2, 2026. The company disclosed on October 30, 2026 that Nasdaq staff determined on October 27, 2026 to delist its Class A ordinary shares unless it requests a hearing.

The cited ground is a closing bid price below USD 1.00 for 30 consecutive Business days. The company is not eligible for a compliance period because it completed a 1-for-25 reverse split on March 16, 2026. It intends to request a hearing by November 3, 2026, which would stay any suspension. Data on the stock page shows a market Capitalization of roughly USD 8.72 million and a float of about 1.06 million shares, so this Penny Stock can swing sharply, and the company said it is considering financing and further share consolidations.

RedCloud Holdings (NASDAQ:RCT): Appeal Filed, Consolidation Approved

RedCloud Holdings (NASDAQ:RCT) was down 33.10 percent to USD 0.0386 in pre-market trading on November 2, 2026. No single announcement dated that day was identified. Nasdaq issued a Staff Delisting Determination on October 13, 2026, the company appealed on October 14, 2026, and shareholders approved a share consolidation on October 30, 2026.

The ratio was reported to have been raised from 20 for one to 100 for one at the meeting. Half-year Revenue rose 34 percent to USD 24.0 million with a net loss of USD 18.5 million. Cash of about USD 767 thousand sits against a stockholders' Deficit of about USD 20.6 million, and a private Placement of 31.7 million unregistered shares to insiders adds dilution risk for this penny stock.

Caring Brands (NASDAQ:CABR): Rising Without a Stated Catalyst

Caring Brands (NASDAQ:CABR) was up 9.73 percent to USD 1.24 in pre-market trading on November 2, 2026. No press release or regulatory filing dated that day was identified, so the gain looks consistent with speculative trading in a low-priced name.

Nasdaq issued a delisting determination on July 15, 2026 because stockholders' Equity of USD 2,091,324 was below the USD 2.5 million minimum. The company later asked a Nasdaq Hearings Panel to confirm compliance, and it cautioned there is no assurance the panel will agree. Cash was USD 1,820,365 at June 30, 2026, with only minimal revenue to date.

Gamehaus (NASDAQ:GMHS): Bid Price Notice and Declining Sales

Gamehaus (NASDAQ:GMHS) was up 12.67 percent to USD 0.7335 in pre-market trading on November 2, 2026. Searches did not identify a specific announcement, so the rise looks like short-term trading in a thinly followed penny stock.

The company received a Nasdaq minimum bid price notification on July 13, 2026. Fiscal 2026 revenue was USD 104.7 million, down 11.4 percent, while Net Income edged up 0.8 percent to USD 3.9 million. Cash was USD 17.6 million at June 30, 2026, and any capital raise could dilute holders.

Milestone Pharmaceuticals (NASDAQ:MIST): Bounce Ahead of April 2027 Deadline

Milestone Pharmaceuticals (NASDAQ:MIST) was up 9.32 percent to USD 0.7980 in pre-market trading on November 2, 2026. No announcement dated that day was identified, and the move looks like a bounce in a heavily sold, low-priced biotech name.

Nasdaq sent a bid price notice on October 23, 2026, giving the company through April 21, 2027 to regain compliance. The notice does not immediately affect its Global Select Market listing. Cash, equivalents and short-term investments were USD 170.6 million at June 30, 2026, though spending is rising faster than product revenue of USD 559 thousand.

Where Things Stand

These five names sit at different stages of the listing process. MASK and RCT face active determinations with hearing or appeal steps, CABR is awaiting the outcome of its own hearing path, and GMHS and MIST are earlier in the bid price process with compliance windows still open. Only MASK has a recent notice as a likely driver, and the rest moved without an identified announcement. Readers may watch the MASK hearing deadline, panel scheduling for RCT and CABR, and any reverse split decisions.